X-Cor Therapeutics Inc

Website
1 Grant St Ste 4
Framingham, MA 01702

X-Cor Therapeutics Inc, based in Baltimore, is pioneering the development of the first commercially available extracorporeal CO2 removal device, specifically designed for patients with hypercarbic respiratory failure. By utilizing ultra-low-blood flow technology, their innovative solution offers a more accessible, affordable, and effective treatment option for individuals suffering from chronic respiratory conditions and acute lung failure.

The company's core technology features a patent-pending hybrid cartridge that enables the removal of excess CO2 from the blood with minimal invasiveness, differing from traditional high-flow systems. Led by a team of experienced professionals from various medical and engineering backgrounds, X-Cor is committed to improving patient outcomes and enhancing the overall quality of life for millions affected by respiratory difficulties.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesMassachusettsFraminghamX-Cor Therapeutics Inc

Partial Data by Infogroup (c) 2024. All rights reserved.